Hims & hers health, inc. HIMS.US Overview

BetaUS StockConsumer Defensive
(No presentation for HIMS)

HIMS AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

HIMS Current Performance

-3.02%

Hims & hers health, inc.

-1.64%

Avg of Sector

-0.40%

S&P500

HIMS Key Information

HIMS Revenue by Segments

HIMS Revenue by Segments

HIMS Revenue by Segments

Browsing restrictions can be lifted for a fee.

HIMS Net Income

HIMS Net Income

HIMS Net Income

Browsing restrictions can be lifted for a fee.

HIMS Cash Flow

HIMS Cash Flow

HIMS Cash Flow

Browsing restrictions can be lifted for a fee.

HIMS Profit Margin

HIMS Profit Margin

HIMS Profit Margin

Browsing restrictions can be lifted for a fee.

HIMS PE Ratio River

HIMS PE Ratio River

HIMS PE Ratio River

Browsing restrictions can be lifted for a fee.

HIMS Financial Forecast

chart

Browsing restrictions can be lifted for a fee.

HIMS Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2024Q4
2024Q3
2024Q2
2024Q1

HIMS Profile

Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products, primarily focusing on wellness, sexual health and wellness, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, biotin, and collagen protein supplements in the wellness category; moisturizer, serums, and face wash in the skincare category; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. In addition, it offers medical consultation services, as well as health and wellness products through wholesale partners. The company is based in San Francisco, California.

Price of HIMS

HIMS FAQ

  • When is HIMS's latest earnings report released?

    The most recent financial report for Hims & hers health, inc. (HIMS) covers the period of 2025Q1 and was published on 2025/03/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating HIMS's short-term business performance and financial health. For the latest updates on HIMS's earnings releases, visit this page regularly.

  • Where does HIMS fall in the P/E River chart?

    According to historical valuation range analysis, Hims & hers health, inc. (HIMS)'s current price-to-earnings (P/E) ratio is 57.02, placing it in the Value zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning conservative. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.

  • What is the operating profit of HIMS?

    According to the latest financial report, Hims & hers health, inc. (HIMS) reported an Operating Profit of 57.9M with an Operating Margin of 9.88% this period, representing a growth of 484.64% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is HIMS's revenue growth?

    In the latest financial report, Hims & hers health, inc. (HIMS) announced revenue of 586.01M, with a Year-Over-Year growth rate of 110.67%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much debt does HIMS have?

    As of the end of the reporting period, Hims & hers health, inc. (HIMS) had total debt of 63.38M, with a debt ratio of 0.07. Long-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.

  • How much cash does HIMS have?

    At the end of the period, Hims & hers health, inc. (HIMS) held Total Cash and Cash Equivalents of 274.96M, accounting for 0.31 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does HIMS go with three margins increasing?

    In the latest report, Hims & hers health, inc. (HIMS) achieved the “three margins increasing” benchmark, with a gross margin of 73.5%%, operating margin of 9.88%%, and net margin of 8.4%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess HIMS's profit trajectory and future growth potential.

  • Is HIMS's EPS continuing to grow?

    According to the past four quarterly reports, Hims & hers health, inc. (HIMS)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at 0.22. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of HIMS?

    Hims & hers health, inc. (HIMS)'s Free Cash Flow (FCF) for the period is 50.05M, calculated as Operating Cash Flow minus Capital Expenditures, representing a rise of 321.31% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.

  • What are the PEG ratio and PE ratio of HIMS?

    The latest valuation data shows Hims & hers health, inc. (HIMS) has a Price-To-Earnings (PE) ratio of 57.02 and a Price/Earnings-To-Growth (PEG) ratio of 0.4. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.